From the Journals

Why So Many on BP Meds Still Miss Target

Most U.S. adults with hypertension missed blood pressure targets—including those on treatment—highlighting gaps in initiation and intensification of therapy, new JAMA data show.

Share

A recent study utilizing National Health and Nutrition Examination Survey data from 2021 to 2023 revealed that almost 80% of US adults with hypertension exceed recommended blood pressure thresholds, with many already on antihypertensive therapy. Among those with uncontrolled blood pressure, 61% were not receiving medication, often due to younger age and lack of health insurance. The findings suggest that significant numbers could improve blood pressure control through medication and lifestyle changes, while those on medication may require intensified treatment, particularly when existing health issues are present.

Original Source(s)

Why So Many on BP Meds Still Miss Target

Most U.S. adults with hypertension missed blood pressure targets—including those on treatment—highlighting gaps in initiation and intensification of therapy, new JAMA data show.

  • by Kathryn Wighton

  • February 2, 2026

  • 3 min

Related Content

Do Urate Targets Influence CV Risk?

Researchers examine whether achieving treat-to-target serum urate levels with urate-lowering treatment affects long-term cardiovascular outcomes in patients with gout.

Quadruple Therapy in HFrEF: What Happens Next?

Study finds high mortality and rehospitalization rates despite guideline-recommended treatment among Medicare beneficiaries.

US Heart Health Progress Stalls

New US cardiovascular statistics document persistent gaps in prevention and treatment across hypertension, diabetes, obesity, and cholesterol management, with marked disparities by age, income, and race.